Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omacor for Hypertriglyceridemia in HIV Patients on HAART
NCT00598910Phase 4Terminated
- Sponsor
- Solvay
- Start
- Aug 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in hypertriglyceridemia comparing Omacor with Placebo (2 arms). Primary endpoint: Percent change in serum triglycerides from baseline to treatment endpoint versus placebo at 12 weeks. Started Aug 2007; status: terminated.
02
Drugs
omega-3-acid triglycerides
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT00598910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00598910.